Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma

BACKGROUND: The determination of HER2 expression status contributes significantly to HER2-targeted therapy in breast carcinoma. However, an economical, efficient, and non-invasive assessment of HER2 is lacking. We aimed to develop a clinicoradiomic nomogram based on radiomics scores extracted from m...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Aqiao, Chu, Xiufeng, Zhang, Shengjian, Zheng, Jing, Shi, Dabao, Lv, Shasha, Li, Feng, Weng, Xiaobo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364617/
https://www.ncbi.nlm.nih.gov/pubmed/35945526
http://dx.doi.org/10.1186/s12885-022-09967-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364617/
https://www.ncbi.nlm.nih.gov/pubmed/35945526
http://dx.doi.org/10.1186/s12885-022-09967-6

Ejemplares similares